BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3928856)

  • 1. HLA-DR expression in a human colonic carcinoma cell line.
    Lampert IA; Kirkland S; Farrell S; Borysiewicz LK
    J Pathol; 1985 Aug; 146(4):337-44. PubMed ID: 3928856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
    Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
    Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
    Guo TL; Mudzinski SP; Lawrence DA
    Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
    Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
    Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    Basham TY; Merigan TC
    J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
    Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell recognition of HLA class II molecules induced by gamma-interferon on a colonic adenocarcinoma cell line (HT29).
    Lundin KE; Sollid LM; Bosnes V; Gaudernack G; Thorsby E
    Scand J Immunol; 1990 Apr; 31(4):469-75. PubMed ID: 2110380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-DR by a human monocyte cell line is under transcriptional control.
    Peterlin BM; Gonwa TA; Stobo JD
    J Mol Cell Immunol; 1984; 1(3):191-200. PubMed ID: 6443852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
    Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
    J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of HLA-DR antigen on human squamous carcinoma by recombinant interferon gamma.
    Koch WM; Dugan E; Diaz LA; Richtsmeier WJ
    Laryngoscope; 1988 May; 98(5):511-5. PubMed ID: 3129628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
    Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
    Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
    Kelley VE; Fiers W; Strom TB
    J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of delayed hypersensitivity reactions by colchicine. II. Colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line.
    Mekori YA; Chowers Y; Ducker I; Klajman A
    Clin Exp Immunol; 1989 Nov; 78(2):230-2. PubMed ID: 12412754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.
    Nickoloff BJ; Basham TY; Merigan TC; Morhenn VB
    Lab Invest; 1984 Dec; 51(6):697-701. PubMed ID: 6209471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.